These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 18562637)

  • 1. Effects of cholesterol-tagged small interfering RNAs targeting 12/15-lipoxygenase on parameters of diabetic nephropathy in a mouse model of type 1 diabetes.
    Yuan H; Lanting L; Xu ZG; Li SL; Swiderski P; Putta S; Jonnalagadda M; Kato M; Natarajan R
    Am J Physiol Renal Physiol; 2008 Aug; 295(2):F605-17. PubMed ID: 18562637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between 12/15-lipoxygenase and COX-2 in mesangial cells: potential role in diabetic nephropathy.
    Xu ZG; Li SL; Lanting L; Kim YS; Shanmugam N; Reddy MA; Natarajan R
    Kidney Int; 2006 Feb; 69(3):512-9. PubMed ID: 16514433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic Histone Modifications Involved in Profibrotic Gene Regulation by 12/15-Lipoxygenase and Its Oxidized Lipid Products in Diabetic Nephropathy.
    Yuan H; Reddy MA; Deshpande S; Jia Y; Park JT; Lanting LL; Jin W; Kato M; Xu ZG; Das S; Natarajan R
    Antioxid Redox Signal; 2016 Mar; 24(7):361-75. PubMed ID: 26492974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Products of 12/15-lipoxygenase upregulate the angiotensin II receptor.
    Xu ZG; Yuan H; Lanting L; Li SL; Wang M; Shanmugam N; Kato M; Adler SG; Reddy MA; Natarajan R
    J Am Soc Nephrol; 2008 Mar; 19(3):559-69. PubMed ID: 18235084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel interactions between TGF-{beta}1 actions and the 12/15-lipoxygenase pathway in mesangial cells.
    Kim YS; Xu ZG; Reddy MA; Li SL; Lanting L; Sharma K; Adler SG; Natarajan R
    J Am Soc Nephrol; 2005 Feb; 16(2):352-62. PubMed ID: 15615821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential behavior of mesangial cells derived from 12/15-lipoxygenase knockout mice relative to control mice.
    Kim YS; Reddy MA; Lanting L; Adler SG; Natarajan R
    Kidney Int; 2003 Nov; 64(5):1702-14. PubMed ID: 14531803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 12-Lipoxygenase Inhibition on Microalbuminuria in Type-1 and Type-2 Diabetes Is Associated with Changes of Glomerular Angiotensin II Type 1 Receptor Related to Insulin Resistance.
    Xu HZ; Cheng YL; Wang WN; Wu H; Zhang YY; Zang CS; Xu ZG
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27164093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 12-lipoxygenase is increased in glucose-stimulated mesangial cells and in experimental diabetic nephropathy.
    Kang SW; Adler SG; Nast CC; LaPage J; Gu JL; Nadler JL; Natarajan R
    Kidney Int; 2001 Apr; 59(4):1354-62. PubMed ID: 11260396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of angiotensin II type 1 receptor blocker on 12-lipoxygenase activity and slit diaphragm protein expression in type 2 diabetic rat glomeruli.
    Xu HZ; Wang WN; Zhang YY; Cheng YL; Xu ZG
    J Nephrol; 2016 Dec; 29(6):775-782. PubMed ID: 27021232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p16ink4a Expression Is Increased through 12-Lipoxygenase in High Glucose-Stimulated Glomerular Mesangial Cells and Type 2 Diabetic Glomeruli.
    Zhang YY; Guo QY; Wu MY; Zang CS; Ma FZ; Sun T; Wang WN; Miao LN; Xu ZG
    Nephron; 2015; 130(2):141-50. PubMed ID: 26022507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of silencing leukocyte-type 12/15-lipoxygenase using short interfering RNAs.
    Li SL; Dwarakanath RS; Cai Q; Lanting L; Natarajan R
    J Lipid Res; 2005 Feb; 46(2):220-9. PubMed ID: 15576842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 12/15-lipoxygenase inhibitors in diabetic nephropathy in the rat.
    Ma J; Natarajan R; LaPage J; Lanting L; Kim N; Becerra D; Clemmons B; Nast CC; Surya Prakash GK; Mandal M; Adler SG
    Prostaglandins Leukot Essent Fatty Acids; 2005 Jan; 72(1):13-20. PubMed ID: 15589395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II type 1 receptor expression is increased via 12-lipoxygenase in high glucose-stimulated glomerular cells and type 2 diabetic glomeruli.
    Xu ZG; Miao LN; Cui YC; Jia Y; Yuan H; Wu M
    Nephrol Dial Transplant; 2009 Jun; 24(6):1744-52. PubMed ID: 19103735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of 12-Lipoxygenase and Its Interaction with Angiotensin II on p21 and p27 Expression in Diabetic Nephropathy.
    Zhang YY; Wang WN; Su SS; Chen B; Sun WX; Wu H; Cheng YL; Xu ZG
    Nephron; 2019; 142(1):61-70. PubMed ID: 30677774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 15-Lipoxygenase worsens renal fibrosis, inflammation, and metabolism in a murine model of ureteral obstruction.
    Montford JR; Bauer C; Rahkola J; Reisz JA; Floyd D; Hopp K; Soranno DE; Klawitter J; Weiser-Evans MCM; Nemenoff R; Faubel S; Furgeson SB
    Am J Physiol Renal Physiol; 2022 Jan; 322(1):F105-F119. PubMed ID: 34866403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency.
    Wolf G; Schanze A; Stahl RA; Shankland SJ; Amann K
    Kidney Int; 2005 Oct; 68(4):1583-9. PubMed ID: 16164635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model.
    Ichinose K; Maeshima Y; Yamamoto Y; Kitayama H; Takazawa Y; Hirokoshi K; Sugiyama H; Yamasaki Y; Eguchi K; Makino H
    Diabetes; 2005 Oct; 54(10):2891-903. PubMed ID: 16186390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated levels of renal and circulating Nop-7-associated 2 (NSA2) in rat and mouse models of diabetes, in mesangial cells in vitro and in patients with diabetic nephropathy.
    Shahni R; Gnudi L; King A; Jones P; Malik AN
    Diabetologia; 2012 Mar; 55(3):825-34. PubMed ID: 22095236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exacerbation of diabetic renal alterations in mice lacking vasohibin-1.
    Hinamoto N; Maeshima Y; Yamasaki H; Nasu T; Saito D; Watatani H; Ujike H; Tanabe K; Masuda K; Arata Y; Sugiyama H; Sato Y; Makino H
    PLoS One; 2014; 9(9):e107934. PubMed ID: 25255225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of kidney ADP-ribosyl cyclase in diabetic nephropathy.
    Kim SY; Park KH; Gul R; Jang KY; Kim UH
    Am J Physiol Renal Physiol; 2009 Feb; 296(2):F291-7. PubMed ID: 19073639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.